Anixa Biosciences Inc (ANIX) shareholders
Close on Nov 17, 2026Market cap $92.82MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Amit Kumar | 6,173,097 | 16.30% | 13D (active) amendment | Jun 4, 2025 |
| Michael Catelani | 2,468,103 | 7.00% | 13D (active) amendment | Jan 5, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ANIX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 1,329,852 | 3.83% | $3.72M | +14,870 | 0.00% |
| UBS Group AG | 585,430 | 1.68% | $1.64M | +33,793 | 0.00% |
| Laird Norton Trust Company, LLC | 578,727 | 1.66% | $1.62M | +12,400 | 0.03% |
| D.A. Davidson & Co. | 539,272 | 1.55% | $1.51M | – | 0.01% |
| Geode Capital Management, LLC | 359,194 | 1.03% | $1.01M | −5,537 | 0.00% |
| Marshall Wace, Llp | 328,332 | 0.94% | $919.33K | +155,153 | 0.00% |
| BlackRock, Inc. | 199,755 | 0.57% | $559.31K | +29,652 | 0.00% |
| Vanguard Fiduciary Trust Co | 192,356 | 0.55% | $538.60K | +1,282 | 0.00% |
| State Street Corp | 159,040 | 0.46% | $445.31K | – | 0.00% |
| Gsa Capital Partners Llp | 117,465 | 0.34% | $329.00K | +18,623 | 0.02% |
| LPL Financial LLC | 111,535 | 0.32% | $312.30K | +30,559 | 0.00% |
| Northern Trust Corp | 69,235 | 0.20% | $193.86K | +2,410 | 0.00% |
| Renaissance Technologies LLC | 59,373 | 0.17% | $166.24K | −1,800 | 0.00% |
| CoreCap Advisors, LLC | 52,020 | 0.15% | $145.66K | – | 0.00% |
| Bank of New York Mellon Corp | 47,442 | 0.14% | $132.84K | – | 0.00% |
| Westside Investment Management, Inc. | 43,000 | 0.12% | $120.40K | −4,000 | 0.02% |
| HighTower Advisors, LLC | 41,150 | 0.12% | $115.22K | −400 | 0.00% |
| Kestra Advisory Services, LLC | 38,000 | 0.11% | $106.40K | −13,000 | 0.00% |
| Corient Private Wealth LLC | 37,400 | 0.11% | $104.72K | +17,400 | 0.00% |
| Gemmer Asset Management LLC | 35,000 | 0.10% | $98.00K | – | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 62 | 5M | 15.4% | 10 / 16 | 7 / 7 | 0M | 0M |
| Q1 2026 | 60 | 5M | 14.6% | 9 / 15 | 10 / 17 | 2M | 1M |
| Q4 2025 | 71 | 6M | 16.4% | 13 / 19 | 13 / 8 | 1M | 1M |
| Q3 2025 | 66 | 5M | 15.6% | 8 / 17 | 8 / 7 | 0M | 0M |
| Q2 2025 | 66 | 5M | 15.4% | 12 / 12 | 12 / 3 | 0M | 0M |
| Q1 2025 | 58 | 6M | 16.1% | 8 / 10 | 8 / 7 | 0M | 0M |
| Q4 2024 | 57 | 6M | 17.0% | 10 / 11 | 9 / 9 | 1M | 0M |
| Q3 2024 | 58 | 6M | 16.2% | 10 / 9 | 13 / 4 | 0M | 0M |
| Q2 2024 | 53 | 6M | 16.0% | 5 / 12 | 10 / 10 | 1M | 1M |
| Q1 2024 | 58 | 5M | 15.4% | 10 / 20 | 7 / 6 | 1M | 0M |
| Q4 2023 | 55 | 4M | 12.8% | 11 / 12 | 11 / 5 | 1M | 0M |
| Q3 2023 | 49 | 4M | 11.3% | 7 / 6 | 15 / 3 | 1M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
12 funds held ANIX in Q2 2026, 80% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of ANIX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 936,927 | 2.70% | $2.62M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 353,878 | 1.02% | $990.86K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 167,262 | 0.48% | $451.61K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 107,494 | 0.31% | $300.98K | 0.02% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 52,694 | 0.15% | $142.27K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 46,645 | 0.13% | $125.94K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 24,102 | 0.07% | $65.08K | 0.00% | May 31, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 21,079 | 0.06% | $59.02K | 0.00% | Jun 30, 2026 |
| Vanguard Balanced Index Fund | 17,968 | 0.05% | $50.31K | 0.00% | Jun 30, 2026 |
| Schwab Total Stock Market Index Fund | 12,785 | 0.04% | $43.72K | 0.00% | Jul 31, 2026 |
| 1290 VT Micro Cap Portfolio | 7,205 | 0.02% | $20.17K | 0.01% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Amit Kumar | Chief Executive Officer, Director | 685,000 | 1.97% | Nov 2, 2026 |
| Michael Catelani | President, COO, & CFO | 50,000 | 0.14% | Sep 30, 2026 |
| Lewis H. Titterton jr | Director | 1,054,003 | 3.03% | Oct 26, 2026 |
| Arnold M. Baskies | Director | 140,572 | 0.40% | Sep 28, 2026 |
| Emily Gottschalk | Director | 45,665 | 0.13% | Jan 6, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Amit Kumar Chief Executive Officer, Director | Oct 30, 2026 | Buy | +5,000 | $3.17 | $15.85K | 685,000 |
| Lewis H. Titterton jr Director | Oct 23, 2026 | Buy | +8,000 | $2.98 | $23.84K | 1,054,003 |
| Amit Kumar Chief Executive Officer, Director | Oct 22, 2026 | Buy | +8,000 | $2.72 | $21.76K | 680,000 |
| Michael Catelani President, COO, & CFO | Sep 30, 2026 | Buy | +5,500 | $2.84 | $15.62K | 50,000 |
| Arnold M. Baskies Director | Sep 24, 2026 | Buy | +5,000 | $2.76 | $13.80K | 140,572 |
| Amit Kumar Chief Executive Officer, Director | Sep 24, 2026 | Buy | +7,000 | $2.78 | $19.46K | 672,000 |
| Lewis H. Titterton jr Director | Sep 23, 2026 | Buy | +49,036 | $2.69 | $131.91K | 1,046,003 |
| Lewis H. Titterton jr Director | Sep 10, 2026 | Buy | +10,000 | $2.73 | $27.30K | 996,967 |
| Amit Kumar Chief Executive Officer, Director | Sep 10, 2026 | Buy | +3,000 | $2.75 | $8.25K | 665,000 |
| Amit Kumar Chief Executive Officer, Director | Sep 10, 2026 | Buy | +5,000 | $2.76 | $13.80K | 662,000 |
| Amit Kumar Chief Executive Officer, Director | Jul 31, 2026 | Buy | +5,000 | $3.47 | $17.35K | 657,000 |
| Arnold M. Baskies Director | Jul 27, 2026 | Tax withholding | −5,428 | $3.46 | $18.78K | 135,572 |
| Arnold M. Baskies Director | Jul 27, 2026 | Option exercise | +6,000 | $3.13 | $18.78K | 141,000 |
| Amit Kumar Chief Executive Officer, Director | Jul 27, 2026 | Buy | +5,000 | $3.44 | $17.20K | 652,000 |
| Amit Kumar Chief Executive Officer, Director | Jul 27, 2026 | Buy | +3,188 | $3.37 | $10.74K | 647,000 |
| Amit Kumar Chief Executive Officer, Director | Jul 24, 2026 | Buy | +3,000 | $3.73 | $11.19K | 643,812 |
| Amit Kumar Chief Executive Officer, Director | Jul 20, 2026 | Buy | +5,000 | $3.46 | $17.30K | 640,812 |
| Lewis H. Titterton jr Director | Jul 20, 2026 | Buy | +12,000 | $3.47 | $41.64K | 986,967 |
| Lewis H. Titterton jr Director | Jul 15, 2026 | Buy | +2,797 | $3.28 | $9.17K | 974,967 |
| Amit Kumar Chief Executive Officer, Director | Jul 10, 2026 | Buy | +5,000 | $3.04 | $15.20K | 635,812 |
| Lewis H. Titterton jr Director | Jun 16, 2026 | Buy | +2,836 | $2.64 | $7.49K | 972,170 |
| Amit Kumar Chief Executive Officer, Director | Jun 12, 2026 | Buy | +21,000 | $2.50 | $52.50K | 630,812 |
| Arnold M. Baskies Director | Jan 28, 2026 | Buy | +10,000 | $3.04 | $30.40K | 135,000 |
| Lewis H. Titterton jr Director | Dec 15, 2025 | Option exercise | +16,000 | $2.92 | $46.72K | 969,334 |
| Amit Kumar Chief Executive Officer | Oct 30, 2025 | Option exercise | +200,000 | $2.92 | $584.00K | 779,925 |
| Amit Kumar Chief Executive Officer | Oct 30, 2025 | Tax withholding | −169,439 | $4.06 | $687.92K | 610,486 |
| Lewis H. Titterton jr Director | Jul 31, 2025 | Buy | +10,000 | $3.08 | $30.80K | 953,334 |
| Amit Kumar Chief Executive Officer | Jul 30, 2025 | Buy | +5,000 | $3.16 | $15.80K | 579,925 |
| Arnold M. Baskies Director | Jul 18, 2025 | Buy | +5,000 | $3.39 | $16.95K | 125,000 |
| Lewis H. Titterton jr Director | Jul 11, 2025 | Buy | +10,000 | $3.14 | $31.40K | 943,334 |
| Amit Kumar Chief Executive Officer | Jul 11, 2025 | Buy | +5,000 | $3.15 | $15.75K | 574,925 |
| Amit Kumar Chief Executive Officer | Jun 4, 2025 | Buy | +10,000 | $2.85 | $28.50K | 569,925 |
| Arnold M. Baskies Director | Jan 28, 2025 | Buy | +5,000 | $2.82 | $14.10K | 120,000 |
| Lewis H. Titterton jr Director | Jan 24, 2025 | Buy | +1,000 | $3.00 | $3.00K | 933,334 |
| Lewis H. Titterton jr Director | Jan 23, 2025 | Buy | +2,000 | $2.91 | $5.82K | 932,334 |
| Lewis H. Titterton jr Director | Jan 22, 2025 | Buy | +2,000 | $3.01 | $6.02K | 930,334 |
| Lewis H. Titterton jr Director | Jan 21, 2025 | Buy | +6,000 | $2.59 | $15.54K | 928,334 |
| Lewis H. Titterton jr Director | Jan 17, 2025 | Buy | +10,000 | $2.57 | $25.70K | 922,334 |
| Michael Catelani President, COO, & CFO | Jan 15, 2025 | Buy | +9,289 | $2.15 | $19.97K | 44,500 |
| Amit Kumar Chief Executive Officer | Jan 15, 2025 | Buy | +43,000 | $2.23 | $95.89K | 559,925 |
| Lewis H. Titterton jr Director | Oct 22, 2024 | Option exercise | +16,000 | $2.58 | $41.28K | 912,334 |
| Lewis H. Titterton jr Director | Jul 31, 2024 | Buy | +5,580 | $3.23 | $18.02K | 896,334 |
| Lewis H. Titterton jr Director | Jul 30, 2024 | Buy | +21,646 | $3.06 | $66.24K | 890,754 |
| Lewis H. Titterton jr Director | Jul 26, 2024 | Buy | +7,700 | $3.03 | $23.33K | 869,108 |
| Arnold M. Baskies Director | Jul 26, 2024 | Buy | +5,000 | $3.09 | $15.45K | 115,000 |
| Lewis H. Titterton jr Director | Jul 25, 2024 | Buy | +796 | $2.81 | $2.24K | 861,408 |
| Lewis H. Titterton jr Director | Jun 14, 2024 | Buy | +4,000 | $2.68 | $10.72K | 860,612 |
| Lewis H. Titterton jr Director | Jun 13, 2024 | Buy | +405 | $2.70 | $1.09K | 856,612 |
| Lewis H. Titterton jr Director | Jun 11, 2024 | Buy | +7,102 | $2.66 | $18.89K | 856,207 |
| Lewis H. Titterton jr Director | Jun 10, 2024 | Buy | +330 | $2.60 | $858 | 849,105 |
| Lewis H. Titterton jr Director | Jun 7, 2024 | Buy | +10,738 | $2.52 | $27.06K | 848,775 |
| Michael Catelani President, COO, & CFO | Jun 7, 2024 | Buy | +6,250 | $2.40 | $15.00K | 35,211 |
| Amit Kumar Chief Executive Officer | Jun 7, 2024 | Buy | +25,000 | $2.41 | $60.25K | 516,925 |
| Michael Catelani President, COO, & CFO | Apr 30, 2024 | Award | +1,189 | $2.52 | $3.00K | 28,961 |
| Lewis H. Titterton jr Director | Apr 9, 2024 | Buy | +15,009 | $3.28 | $49.23K | 838,037 |
| Amit Kumar Chief Executive Officer | Mar 15, 2024 | Buy | +30,000 | $3.22 | $96.60K | 491,925 |
| Arnold M. Baskies Director | Mar 15, 2024 | Buy | +10,000 | $3.63 | $36.30K | 110,000 |
| Michael Catelani President, COO & CFO | Oct 31, 2023 | Award | +1,117 | $2.69 | $3.00K | 27,772 |
| Lewis H. Titterton jr Director | Oct 10, 2023 | Option exercise | +16,000 | $2.58 | $41.28K | 823,028 |
| Amit Kumar Chief Executive Officer, Director | Jul 31, 2023 | Sale | −11,800 | $3.57 | $42.13K | 461,925 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Anixa Biosciences's stock actually held short. Settlement fails (shares not delivered on time) peaked at 53,772 shares on Aug 20, 2026 over the last 90 days.
See a number that looks wrong?